Navigation Links
Breast cancer diagnosis, mammography improved by considering patient risk: INFORMS paper
Date:6/17/2014

A new approach to examining mammograms that takes into account a woman's health risk profile would reduce the number of cancer instances missed and also cut the number of false positives, according to a paper being presented at a conference of the Institute for Operations Research and the Management Sciences (INFORMS).

Mehmet U.S. Ayvaci of the University of Texas Dallas will present his research group's findings about the role of risk profiling in the interpretation of mammograms at Advances in Decision Analysis, a conference sponsored by the INFORMS Decision Analysis Society (DAS). The conference takes place June 16-18 at Georgetown University in Washington, DC.

The researchers found that providing radiologists with the patient's risk profile information for breast cancer at the most advantageous time when examining the mammogram , together with statistical weighting based on profile risk, reduces false negatives by 3.7%, thus alerting women whose cancer would have gone undiagnosed at an early stage, when treatment is most effective. It also reduces false positives by 3.23%, thus cutting unnecessary healthcare costs and sparing patients' needless distress.

Risk factors include family history, reproductive history, age, and ethnicity, and others forming the risk profile information.

The paper examines the tricky questions of whether providing risk profile information about women being screened for cancer biases radiologists and, if there is bias, whether this bias actually helps make readings more accurate.

Historically, available clinical evidence has been inconclusive on the use of profile information when interpreting mammograms. One position is that profile information helps radiologists make better decisions and should be employed when reading mammograms. A contradictory position holds that profile information may bias the radiologists. However, whether bias always causes harm is unclear.

The authors explored profile information and potential bias in mammography interpretation using a decision science technique called linear opinion pooling, which assigns weights to better aggregate probability estimates.

They analyzed the decision performance of three groups: (1) a mammogram-only reading, with no risk profile information about the patient, (2) an unbiased reading, in which radiologists consult the risk profile after examining the mammogram and (3) biased or "influenced" readings, in which radiologists consult a woman's risk profile as they examine the mammogram. Then they examined the conditions in which profile information could help improve biopsy decisions.

Numerical analysis using a clinical dataset from the Breast Cancer Surveillance Consortium revealed that use of profile information with an appropriate weight could reduce the false positives and the number of missed cancers when compared to cases where profile information was not examined.

Breast cancer is the second most deadly non-skin cancer. In 2013, approximately 232,000 breast cancer diagnoses were made and about 39,000 women died from the disease.


'/>"/>

Contact: Barry List
barry.list@informs.org
443-794-5182
Institute for Operations Research and the Management Sciences
Source:Eurekalert

Related medicine news :

1. Eliminating the good cholesterol receptor may fight breast cancer
2. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Scientists uncover multiple faces of deadly breast cancer
5. Depo-Provera Birth Control Might Raise Breast Cancer Risk
6. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
7. Mayo Clinic launches whole genome breast cancer study
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Teen Drinking May Boost Odds of Precancerous Breast Changes
10. Stress contributes to cognitive declines in women with breast cancer, researcher says
11. Breast Cancer Treatment Side Effects May Last for Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... 27, 2017 , ... Much attention has been paid to the problem of ... opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain ... overdoses in male populations.(1) , The proportion of women using illicit drugs is also ...
(Date:2/27/2017)... ... 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working as ... Now, she writes about God, when she isn’t swimming as a performing mermaid. , Her ... BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, before ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... on laser diffraction analysis as a tool to characterize particle size distributions in ... to obtain improved results and novel scientific findings. It describes methods of optimized ...
(Date:2/27/2017)... POUGHKEEPSIE, N. Y. (PRWEB) , ... February 27, 2017 , ... ... Society ( ILADS ) has disclosed that despite scientific studies, the Center for Disease ... of chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is ... team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... OCEAN VIEW, Delaware , February 27, 2017 ... (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode ... Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., ... , Poland , Russia , ... Japan , South Korea , Taiwan ...
(Date:2/27/2017)... , Feb. 27, 2017   Royal Philips ... a global leader in health technology, today announced ... Administration (FDA) to market its ElastQ Imaging capability, ... of ultrasound systems. ElastQ Imaging enables simultaneous imaging ... is essential for the diagnosis of various liver ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
Breaking Medicine Technology: